Positron Emission Tomography/Computed Tomography with 89Zr-girentuximab Can Aid in Diagnostic Dilemmas of Clear Cell Renal Cell Carcinoma Suspicion-Reference-Cited by-同舟云学术

Positron Emission Tomography/Computed Tomography with 89Zr-girentuximab Can Aid in Diagnostic Dilemmas of Clear Cell Renal Cell Carcinoma Suspicion

Published:2018-09 Issue:3 Volume:74 Page:257-260
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Hekman Marlène C.H.,Rijpkema Mark,Aarntzen Erik H.,Mulder Sasja F.,Langenhuijsen Johan F.,Oosterwijk Egbert,Boerman Otto C.,Oyen Wim J.G.,Mulders Peter F.A.

Publisher

Elsevier BV

Subject

Urology

Reference7 articles.

1. Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy;Stillebroer;Eur Urol,2010

2. Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial;Divgi;Lancet Oncol,2007

3. Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial;Divgi;J Clin Oncol,2013

4. Indium-111-labeled girentuximab immunoSPECT as a diagnostic tool in clear cell renal cell carcinoma;Muselaers;Eur Urol,2013

5. Pairwise comparison of 89Zr- and 124I-labeled cG250 based on positron emission tomography imaging and nonlinear immunokinetic modeling: in vivo carbonic anhydrase IX receptor binding and internalization in mouse xenografts of clear-cell renal cell carcinoma

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalised PET imaging in oncology: an umbrella review of meta-analyses to guide the appropriate radiopharmaceutical choice and indication;European Journal of Nuclear Medicine and Molecular Imaging;2024-09-11

2. [89Zr]Zr-girentuximab for PET–CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial;The Lancet Oncology;2024-09

3. [18F]RCCB6 Immuno-Positron Emission Tomography/Computed Tomography for Postoperative Surveillance in Clear Cell Renal Cell Carcinoma: A Pilot Clinical Study;European Urology;2024-07

4. [99mTc]Tc-sestamibi for the differential diagnosis of renal masses: a study protocol;Clinical and Translational Imaging;2024-06-26

5. Evaluation of PET/CT imaging with [89Zr]Zr-DFO-girentuximab: a phase 1 clinical study in Japanese patients with renal cell carcinoma (Zirdac-JP);Japanese Journal of Clinical Oncology;2024-06-12